Rothschild Gerson, Zhao Xudong, Iavarone Antonio, Lasorella Anna
Institute for Cancer Genetics, 1150 St. Nicholas Ave., Columbia University, New York, NY 10032, USA.
Mol Cell Biol. 2006 Jun;26(11):4351-61. doi: 10.1128/MCB.01743-05.
A precise balance between proliferation and differentiation must be maintained during neural development to obtain the correct proportion of differentiated cell types in the adult nervous system. The basic helix-loop-helix (bHLH) transcription factors known as E proteins and their natural inhibitors, the Id proteins, control the timing of differentiation and terminal exit from the cell cycle. Here we show that progression into S phase of human neuroblastoma cells is prevented by E proteins and promoted by Id2. Cyclin-dependent kinase inhibitors (CKI) have been identified as key effectors of cell cycle arrest in differentiating cells. However, p57Kip2 is the only CKI that is absolutely required for normal development. Through the use of global gene expression analysis in neuroblastoma cells engineered to acutely express the E protein E47 and Id2, we find that p57Kip2 is a target of E47. Consistent with the role of Id proteins, Id2 prevents activation of p57Kip2 expression, and the retinoblastoma tumor suppressor protein, a known Id2 inhibitor, counters this activity. The strong E47-mediated inhibition of entry into S phase is entirely reversed in cells in which expression of p57Kip2 is silenced by RNA interference. During brain development, expression of p57Kip2 is opposite that of Id2. Our findings identify p57Kip2 as a functionally relevant target recruited by bHLH transcription factors to induce cell cycle arrest in developing neuroblasts and suggest that deregulated expression of Id proteins may be an epigenetic mechanism to silence expression of this CKI in neural tumors.
在神经发育过程中,必须维持增殖与分化之间的精确平衡,以在成体神经系统中获得正确比例的分化细胞类型。被称为E蛋白的碱性螺旋-环-螺旋(bHLH)转录因子及其天然抑制剂Id蛋白,控制着分化的时间和细胞周期的终末退出。在此我们表明,E蛋白可阻止人类神经母细胞瘤细胞进入S期,而Id2则促进这一过程。细胞周期蛋白依赖性激酶抑制剂(CKI)已被确定为分化细胞中细胞周期停滞的关键效应因子。然而,p57Kip2是正常发育绝对必需的唯一CKI。通过对经基因工程改造可急性表达E蛋白E47和Id2的神经母细胞瘤细胞进行全基因组表达分析,我们发现p57Kip2是E47的一个靶标。与Id蛋白的作用一致,Id2可阻止p57Kip2表达的激活,而视网膜母细胞瘤肿瘤抑制蛋白(一种已知的Id2抑制剂)可对抗这种活性。在通过RNA干扰使p57Kip2表达沉默的细胞中,E47介导的对进入S期的强烈抑制作用完全被逆转。在脑发育过程中,p57Kip2的表达与Id2相反。我们的研究结果确定p57Kip2是bHLH转录因子招募的一个功能相关靶标,可诱导发育中的神经母细胞发生细胞周期停滞,并表明Id蛋白的表达失调可能是一种表观遗传机制,可使神经肿瘤中这种CKI的表达沉默。